We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+34.39%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$65.8B
AUM Growth
+$8.44B
Cap. Flow
-$768M
Cap. Flow %
-1.17%
Top 10 Hldgs %
21.16%
Holding
3,797
New
262
Increased
1,942
Reduced
1,268
Closed
186

Sector Composition

Rank Sector Weight
1 Technology 10.51%
2 Financials 8.9%
3 Healthcare 8.23%
4 Industrials 6.82%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEMG
3726
DELISTED
SEMGROUP CORPORATION
SEMG
-11,343
Closed -$156K
AQ
3727
DELISTED
Aquantia Corp. Common Stock
AQ
-12,800
Closed -$112K
PETX
3728
DELISTED
Aratana Therapeutics, Inc.
PETX
-10,650
Closed -$65K
TVPT
3729
DELISTED
Travelport Worldwide Limited
TVPT
-564,160
Closed -$8.81M
MRT
3730
DELISTED
MedEquities Realty Trust, Inc.
MRT
-53,537
Closed -$366K
MXWL
3731
DELISTED
Maxwell Technologies Inc
MXWL
-11,160
Closed -$23K
HZNP
3732
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-127,300
Closed -$203K
TFCFA
3733
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-108,509
Closed -$5.22M
TFCF
3734
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
-46,443
Closed -$2.22M
NTRI
3735
DELISTED
NutriSystem, Inc.
NTRI
-93,503
Closed -$4.1M
SGYP
3736
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-43,718
Closed -$5K
MSF
3737
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
-77,755
Closed -$1.25M
MB
3738
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
-6,384
Closed -$232K
LOXO
3739
DELISTED
Loxo Oncology, Inc
LOXO
-15,638
Closed -$2.19M
NFX
3740
DELISTED
Newfield Exploration
NFX
-54,107
Closed -$793K
ATHN
3741
DELISTED
Athenahealth, Inc.
ATHN
-4,686
Closed -$618K
DNB
3742
DELISTED
Dun & Bradstreet
DNB
-38,170
Closed -$5.45M
EMITF
3743
DELISTED
Elbit Imaging Ltd
EMITF
-60,800
Closed -$79K
P
3744
DELISTED
Pandora Media Inc
P
-24,352
Closed -$197K
VVC
3745
DELISTED
Vectren Corporation
VVC
-19,480
Closed -$1.4M
WRD
3746
DELISTED
WildHorse Resource Development
WRD
-196,539
Closed -$2.77M
ESIO
3747
DELISTED
Electro Scientific Industries
ESIO
-71,065
Closed -$2.13M
ENLK
3748
DELISTED
EnLink Midstream Partners, LP
ENLK
-209,128
Closed -$2.3M
EIP
3749
DELISTED
Eaton Vance Pennsylvania Municipal Bond Fund
EIP
-15,000
Closed -$171K
CYHHZ
3750
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
-42,246
Closed -$1K

Similar funds

Raymond James & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Raymond James & Associates held 3,797 positions worth $65.8B, up 15% from $57.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q1 2019 filing shows 262 new, 1,942 increased, 1,268 reduced and 186 closed positions. Its largest new stake was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M. The largest sale was TotalEnergies, an estimated $2.56B.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.8% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2019 buy was iShares Currency Hedged MSCI Japan ETF: 509,963 shares worth $15.7M.
  • Raymond James & Associates added most to iShares MSCI USA Min Vol Factor ETF in Q1 2019, an estimated $371M increase.
  • Raymond James & Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $2.56B.
  • Raymond James & Associates fully exited iShares Core 80/20 Aggressive Allocation ETF in Q1 2019, selling an estimated $26.3M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $65.8B portfolio in Q1 2019.
  • Raymond James & Associates opened 262 new positions and closed 186 in Q1 2019.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $65.8B.

Based on Raymond James & Associates's 13F filing for Q1 2019, filed 6 May 2019.